MedPath

Use of a Hypercaloric and Hyperprotein Supplement Enriched with Immunonutrients in Multi-pathological Malnourished Patients to Improve the Incidence and Prevalence of Pressure Sores

Phase 4
Completed
Conditions
Multimorbidity
Comorbidity
Malnutrition
Pressure Ulcer Prevention
Registration Number
NCT06726486
Lead Sponsor
University of Cadiz
Brief Summary

The goal of this study is to evaluate the efficacy of a hypercaloric, hyperproteic enteral formula enriched with immunonutrients in preventing and treating pressure injuries in hospitalized malnourished patients.

Participants will take enteral formula (a complete hyperproteic and hypercaloric oral nutritional supplement with a fibre mixture enriched in omega 3, L-arginine and nucleotides, providing vitamin C and Zinc) or a hyperproteic and hypercaloric oral nutritional supplement with fibre mixture every day for 30 days.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
69
Inclusion Criteria
  • Hospitalized chronic patients with complex needs in the Internal Medicine Department of a regional hospital.
  • Malnourished or at risk of malnutrition.
  • Moderate-high risk of developing pressure-related injuries or the presence of pressure-related injuries.
Exclusion Criteria
  • Limitations in oral intake (due to pathologies, state of health, among others).
  • Contraindications for using the oral route and digestive intolerance or allergy to any of the components of the products.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Presence of pressure-related injuries15 and 30 days

Dichotomous variable: Yes/No.

Risk of developing pressure-related injuries15 and 30 days

Measurement instrument: Braden scale (low risk, moderate risk, high risk).

Categorization of pressure-related injuries15 and 30 days

Measurement instrument: PUSH scale (I, II, III, IV).

Pressure-related injuries healing15 and 30 days

Measurement instrument: PUSH scale (closed, epithelial tissue, granulation tissue, sphacelium, necrotic tissue).

Degree of dependence0, 15, and 30 days.

Measurement instruments (description): Barthel score (independent, mild, moderate, severe).

Weight loss0, 15 and 30 days.

Measurement instruments (description): Weight scale (kg).

% of dietary intake15 and 30 days.

0%, 25%, 50%, 75%, 100% intake.

ONS adherence15 and 30 days.

0%, 25%, 50%, 75%, 100% intake.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Punta Europa University of Cadiz

🇪🇸

Algeciras, Cadiz, Spain

© Copyright 2025. All Rights Reserved by MedPath